Alcensa, Xalkori, and several other precision cancer medicines target ALK positive lung cancer and improve treatment.

Cancer diagnoses drop as many skip screening due to COVID-19. COVID may lead to 10,000 excess cancer deaths

Lobrena - a third generation ALK inhibitor drug with excellent CNS activity

The COVID-19 pandemic is creating a new normal-patients need to adapt to reduce risk and understand treatment decisions.

3D Bioprinting is and innovative approach to provide a revolutionized personal treatment plan for cancer patients

Understanding coronavirus test results - can testing determine your immunity? FDA approves first self test for home use.

Vitamin D is important for bone health and has other benefits, don't get caught in the dark this winter.

The sudden, rapid death of cancer cells in response to cancer treatment causes metabolic and electrolyte disturbances.